Literature DB >> 12193783

Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia.

Igor Splawski1, Katherine W Timothy, Michihiro Tateyama, Colleen E Clancy, Alka Malhotra, Alan H Beggs, Francesco P Cappuccio, Giuseppe A Sagnella, Robert S Kass, Mark T Keating.   

Abstract

Every year, approximately 450,000 individuals in the United States die suddenly of cardiac arrhythmia. We identified a variant of the cardiac sodium channel gene SCN5A that is associated with arrhythmia in African Americans (P = 0.000028) and linked with arrhythmia risk in an African-American family (P = 0.005). In transfected cells, the variant allele (Y1102) accelerated channel activation, increasing the likelihood of abnormal cardiac repolarization and arrhythmia. About 13.2% of African Americans carry the Y1102 allele. Because Y1102 has a subtle effect on risk, most carriers will never have an arrhythmia. However, Y1102 may be a useful molecular marker for the prediction of arrhythmia susceptibility in the context of additional acquired risk factors such as the use of certain medications.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193783     DOI: 10.1126/science.1073569

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  146 in total

1.  Human population genetic structure and inference of group membership.

Authors:  Michael J Bamshad; Stephen Wooding; W Scott Watkins; Christopher T Ostler; Mark A Batzer; Lynn B Jorde
Journal:  Am J Hum Genet       Date:  2003-01-28       Impact factor: 11.025

2.  Overwhelming number of AA deaths occur in police custody.

Authors:  Pamela E Southall; Joseph P Pestaner
Journal:  J Natl Med Assoc       Date:  2003-08       Impact factor: 1.798

3.  Epidemiology and genetics of sudden cardiac death.

Authors:  Rajat Deo; Christine M Albert
Journal:  Circulation       Date:  2012-01-31       Impact factor: 29.690

4.  Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing.

Authors:  David J Tester; Argelia Medeiros-Domingo; Melissa L Will; Carla M Haglund; Michael J Ackerman
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

5.  The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes.

Authors:  Elijah R Behr; Craig January; Eric Schulze-Bahr; Andrew A Grace; Stefan Kääb; Monica Fiszman; Shaniece Gathers; Shaavhrée Buckman; Ashraf Youssef; Munir Pirmohamed; Dan Roden
Journal:  Eur Heart J       Date:  2012-07-02       Impact factor: 29.983

Review 6.  Genetics of sudden cardiac death caused by ventricular arrhythmias.

Authors:  Roos F Marsman; Hanno L Tan; Connie R Bezzina
Journal:  Nat Rev Cardiol       Date:  2013-12-10       Impact factor: 32.419

7.  Genetics can contribute to the prognosis of Brugada syndrome: a pilot model for risk stratification.

Authors:  Elena Sommariva; Carlo Pappone; Filippo Martinelli Boneschi; Chiara Di Resta; Maria Rosaria Carbone; Erika Salvi; Pasquale Vergara; Simone Sala; Daniele Cusi; Maurizio Ferrari; Sara Benedetti
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

Review 8.  Drug-induced torsades de pointes and implications for drug development.

Authors:  Robert R Fenichel; Marek Malik; Charles Antzelevitch; Michael Sanguinetti; Dan M Roden; Silvia G Priori; Jeremy N Ruskin; Raymond J Lipicky; Louis R Cantilena
Journal:  J Cardiovasc Electrophysiol       Date:  2004-04

Review 9.  Genetics of acquired long QT syndrome.

Authors:  Dan M Roden; Prakash C Viswanathan
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

10.  Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome.

Authors:  David W Van Norstrand; David J Tester; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2008-02-16       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.